This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
The role of mesenchymal stromal cells in immune modulation of COVID-19: focus on cytokine storm
Stem Cell Research & Therapy Open Access 18 September 2020
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Rights and permissions
About this article
Cite this article
Sheridan, C. First off-the-shelf mesenchymal stem cell therapy nears European approval. Nat Biotechnol 36, 212–214 (2018). https://doi.org/10.1038/nbt0318-212a
Published:
Issue Date:
DOI: https://doi.org/10.1038/nbt0318-212a
This article is cited by
-
The role of mesenchymal stromal cells in immune modulation of COVID-19: focus on cytokine storm
Stem Cell Research & Therapy (2020)
-
The Therapeutic Potential of Mesenchymal Stromal Cells in the Treatment of Chemotherapy-Induced Tissue Damage
Stem Cell Reviews and Reports (2019)
-
Biological functions of mesenchymal stem cells and clinical implications
Cellular and Molecular Life Sciences (2019)